<DOC>
	<DOC>NCT00239798</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of FTY720 combined with cyclosporine and corticosteroids in patients receiving a kidney transplant.</brief_summary>
	<brief_title>Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Fingolimod Hydrochloride</mesh_term>
	<criteria>Inclusion Criteria Patients who have completed the 12 Month visit of the Core trial either on or off study drug. Female capable of becoming pregnant are required to have a medically approved method of birth control until 3 Month after study medication was stopped. Exclusion Criteria None</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Transplantation, kidney, organ transplant</keyword>
</DOC>